Modular Medical Inc

NASDAQ MODD

Data sourced from iex and EODHD
Download Data

Modular Medical Inc Income Statement 2004 - 2023

This table shows the Income Statement for Modular Medical Inc going from 2004 until 2023. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-12-31 2004-09-30
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Cost of Revenue
M 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Profit
M -1 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Expenses
M 16 4 4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 5 4 5 5 6 6 7 7 6 5 4 3 3 3 3 2 2 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - -
Research and Development (R&D) Expenses
M 11 8 9 9 9 8 8 8 7 6 5 4 4 4 3 3 3 3 2 2 1 1 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Expenses
M -1 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Costs and Expenses
M 16 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Income
M -17 -12 -14 -14 -14 -15 -15 -15 -13 -11 -9 -7 -8 -7 -6 -5 -4 -4 -3 -3 -2 -1 -1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Expense
M 0 0 0 0 1 2 2 3 2 1 1 - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Non-operating Income/Expense
M 0 0 0 0 -1 -1 -1 -1 -1 -1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 0 0 0 0 0 - - - - - - - - - 0 0 0 0 - - - - - -
EBT
M -17 -11 -14 -14 -15 -16 -17 -19 -16 -13 -10 -7 -8 -7 -6 -5 -4 -4 -3 -3 -2 -1 -1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Income Tax Provision
M 0 0 0 0 1 2 2 2 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - -
Income after Tax
M -8 -8 -10 -14 -15 -18 -19 -21 -18 -12 -9 -4 -4 -4 -2 -2 -1 -1 -1 -1 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - -
Non-Controlling Interest
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Net Income
M -7 -7 -14 -14 -15 -16 -17 -19 -16 -13 -10 -7 -8 -7 -6 -5 -3 -2 -1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 18,258,347.25 16,062,588.00 2,729,866,703.75 2,728,277,865.25 9,848,042.75 8,705,113.50 7,557,356.50 6,450,973.50 6,311,303.75 6,285,027.00 6,254,057.25 6,202,400.50 6,129,329.50 6,056,256.75 5,995,432.00 5,954,870.25 5,869,701.75 5,784,533.25 5,627,284.50 5,471,912.50 5,399,832.25 5,327,752.00 4,099,965.00 2,872,178.00 1,644,391.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,604.00 416,600.25 416,600.25 416,600.25 381,274.00 516,643.00 480,925.25 445,207.50 473,882.75 312,488.67 331,866.50 390,000.00
EBITDA
M -16 -11 -14 -14 -14 -15 -15 -14 -12 -10 -8 -7 -7 -7 -6 -5 -4 -4 -3 -3 -2 -1 -1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation and Amortization
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBIT
M -17 -12 -14 -14 -14 -15 -15 -15 -12 -10 -8 -7 -8 -7 -6 -5 -4 -4 -3 -3 -2 -1 -1 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% -0.17 -0.17 -0.11 -0.08 -3.00 -8.22 -8.21 -12.75 -9.77 -6.07 -6.08 -0.05 -0.08 -0.08 -0.08 -0.08 -0.16 -0.16 -0.16 -0.16 -0.44 -0.38 -0.38 -0.38 -0.31 - - - - - - - - - - - - - - - - - - - - - - - - - -602.16 -602.16 -602.16 -602.16 -16.81 -16.81 -16.81 -16.81 - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Profit Margin
% -1,007.14 100.00 100.00 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 49.36 49.36 49.36 49.36 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Income Margin
% -26,792.86 -26,792.86 -26,792.86 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -154.01 -154.01 -154.01 -154.01 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Net Income Margin
% -26,692.86 -26,692.86 -26,692.86 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% -26,378.57 -26,378.57 -26,378.57 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -154.01 -154.01 -154.01 -154.01 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBIT Ratio
% -26,792.86 -26,792.86 -26,792.86 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBT Ratio
% -26,692.86 -26,692.86 -26,692.86 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -372.64 -372.64 -372.64 -372.64 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

StockViz Staff

September 19, 2024

Any question? Send us an email